SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
US academic drug discovery
7 references·3 citing·28 second hop
US academic drug discovery (2011)US academic drug discoveryThe Role of Public-Sector Research in the Discovery of Drugs and Vaccines (2011)The Role of Public-Sector Res…The importance of new companies for drug discovery: origins of a decade of new drugs (2010)The importance of new compani…Open access chemical and clinical probes to support drug discovery (2009)Open access chemical and clin…Lessons from 60 years of pharmaceutical innovation (2009)Lessons from 60 years of phar…Drug discovery: new models for industry–academic partnerships (2008)Drug discovery: new models fo…Drug discovery in jeopardy (2006)Drug discovery in jeopardyAcademia–industry partnerships in drug discovery (2006)Academia–industry partnership…Ten Years of Medicinal Chemistry (2005–2014) in the Journal of Medicinal Chemistry: Country of Contributors, Topics, and Public–Private Partnerships (2016)Ten Years of Medicinal Chemis…Open for collaboration: an academic platform for drug discovery and development at SciLifeLab (2016)Open for collaboration: an ac…Academic–Industrial Collaboration: Toward the Consilience of Two Solitudes (2015)Academic–Industrial Collabora…Interorganizational Collaboration and the Locus of Innovation: Networks of Learning in Biotechnology (1996)The price of innovation: new estimates of drug development costs (2003)The black swan: the impact of the highly improbable (2007)The productivity crisis in pharmaceutical R&D (2011)THE WORLD MEDICINES SITUATION 2011 (2011)An index to quantify an individual's scientific research output (2005)Are Patents Impeding Medical Care and Innovation? (2010)Role and reality: technology transfer at Canadian universities (2010)Governing Medical Knowledge Commons (2017)Prospects for productivity (2004)The case for open‐access chemical biology (2009)Drug discovery management, small is still beautiful: Why a number of companies get it wrong (2011)Translational research: the changing landscape of drug discovery (2012)Regional advantage: culture and competition in Silicon Valley and Route 128 (1994)The New Argonauts. Regional Advantage in a Global Economy (2009)Orphan drug development: an economically viable strategy for biopharma R&D (2012)Asymmetric Growth and Institutions in an Interdependent World (2017)The $800 Million Pill (2004)Finding improved medicines: the role of academic–industrial collaboration (2005)The cost of drug development: A systematic review (2011)Diagnosing the decline in pharmaceutical R&D efficiency (2012)Drug discovery in pharmaceutical industry: productivity challenges and trends (2012)Believe it or not: how much can we rely on published data on potential drug targets? (2011)The Roles Of Academia, Rare Diseases, And Repurposing In The Development Of The Most Transformative Drugs (2015)Measuring the knowledge translation and convergence in pharmaceutical innovation by funding-science-technology-innovation linkages analysis (2018)Public sector financial support for late stage discovery of new drugs in the United States: cohort study (2019)Changing R&D models in research-based pharmaceutical companies (2016)Exploring different approaches to improve the success of drug discovery and development projects: a review (2020)
this work references cited by second hop

References

  • 2009Lessons from 60 years of pharmaceutical innovation1,207 cited
  • 2010The importance of new companies for drug discovery: origins of a decade of new drugs344 cited
  • 2011The Role of Public-Sector Research in the Discovery of Drugs and Vaccines245 cited
  • 2006Drug discovery in jeopardy209 cited
  • 2008Drug discovery: new models for industry–academic partnerships140 cited
  • 2009Open access chemical and clinical probes to support drug discovery130 cited
  • 2006Academia–industry partnerships in drug discovery19 cited

Cited by

  • 2016Open for collaboration: an academic platform for drug discovery and development at SciLifeLab13 cited
  • 2015Academic–Industrial Collaboration: Toward the Consilience of Two Solitudes9 cited
  • 2016Ten Years of Medicinal Chemistry (2005–2014) in the Journal of Medicinal Chemistry: Country of Contributors, Topics, and Public–Private Partnerships9 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work